-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Phathom Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q3 2023.
- Phathom Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2023 was $100K, a 50% decline year-over-year.
- Phathom Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2023 was $500K, a 2.72% decline year-over-year.
- Phathom Pharmaceuticals, Inc. annual Depreciation for 2022 was $600K, a 20% increase from 2021.
- Phathom Pharmaceuticals, Inc. annual Depreciation for 2021 was $500K, a 66.7% increase from 2020.
- Phathom Pharmaceuticals, Inc. annual Depreciation for 2020 was $300K, a 3650% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)